Aclaris Therapeutics, Inc.
Aclaris Therapeutics, Inc. (ACRS) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · ACRS · as of Jun 8, 2026
Key Statistics
Explore Aclaris Therapeutics, Inc. Data
acrs stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 16 · Buy rate: 81.3%
The ACRS analyst consensus is Buy, based on ratings from 16 Wall Street analysts over the past 3 months. The average 12-month price target is $10.60, representing +143.12% upside from the current price of $4.36.
Competitors & Peers
acrs competitorsACRS
ALLO
BIOA
CABA
EDIT
MASSStock Performance
Full HistoryAbout Aclaris Therapeutics, Inc.
Aclaris Therapeutics, Inc. a biopharmaceutical firm operating in the United States, is currently in the clinical development phase, focused on creating novel therapeutic agents for various immune-inf…
what is aclaris therapeutics, inc. · acrs stock overview · aclaris therapeutics, inc. company profile · who is aclaris therapeutics, inc. ceo · acrs NASDAQ · aclaris therapeutics, inc. headquarters · aclaris therapeutics, inc. business segments
About Stock Overview & Key Data
Aclaris Therapeutics, Inc. (ACRS) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Oct 6, 2015. As of the latest trading session, ACRS stock price is $4.36, with a market capitalization of $525.8M. The stock has returned +192.62% over the past 12 months and +44.85% year-to-date.
According to 16 Wall Street analysts, the consensus rating for Aclaris Therapeutics, Inc. stock is Buy, with an average 12-month price target of $10.60. In fiscal year 2025, Aclaris Therapeutics, Inc. reported revenue of $7.8M and net income of -$64.9M. For detailed data — including Aclaris Therapeutics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Aclaris Therapeutics, Inc. (ACRS) stock price is $4.36. The stock is traded on NASDAQ under the ticker symbol ACRS. The 52-week range is $1.34 – $5.15.